ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Xenon Pharmaceuticals (XENE) Technical (Analysis) Reports Xenon Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Xenon Pharmaceuticals (XENE)

Technical Analysis Report for NASDAQ stock XENE Xenon Pharmaceuticals. Dated: 05 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock XENE Xenon Pharmaceuticals then click here. or read Experts views on Xenon Pharmaceuticals or Forecast & share price targets of Xenon Pharmaceuticals

Xenon Pharmaceuticals Opened at 64.77 and Closed at: 64.34, which is 0.51% of previous session's close. It moved within a range of 64.00 and 66.40
The session was a Bearish session with an average volume of 317148, which is -101.55% of previous session's volumes.

  • Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Dead cross was found 6 days back on short term averages

Support for tomorrow is 62.97 and resistance for tomorrow is 65.37
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 63.43, 62.51 resistance for tomorrow's hourly charts is 65.83, 67.31

10 Day SMA for Xenon Pharmaceuticals (XENE) is 64.21 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Xenon Pharmaceuticals (XENE) is 65.67 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Xenon Pharmaceuticals (XENE) is 59.98 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 58.08 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Xenon Pharmaceuticals is 50.6 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Xenon Pharmaceuticals is at 65.67 and 200 DMA is at 50.6, while 50 DMA and 100 DMA are at 59.98 and 58.08 respectively

Xenon Pharmaceuticals (XENE) moving average of 20 SMA is at 65.67 and 20 EMA is at 64.1

Xenon Pharmaceuticals (XENE) moving average of 50 SMA is at 59.98 and 50 EMA is at 61.45

Xenon Pharmaceuticals (XENE) moving average of 100 SMA is at 58.08 and 100 EMA is at 57.68

Xenon Pharmaceuticals (XENE) moving average of 200 SMA is at 50.6 and 200 EMA is at 52.27

Xenon Pharmaceuticals has performed better than Viking Therapeutics in short term. Holding Xenon Pharmaceuticals could be a better choice for now!

Bio Techne has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Bio Techne, about 7.69% more returns!

Sol Gel has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Sol Gel, about 26.37% more returns!

Incyte Corporation has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Incyte Corporation, about 9.33% more returns!

Henry Schein has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 12.88% more returns!

Geron Corporation has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Geron Corporation, about 14.69% more returns!

Xenon Pharmaceuticals has performed better than Fortress Biotech in short term. Holding Xenon Pharmaceuticals could be a better choice for now!

Xenon Pharmaceuticals has performed better than Equillium Inc in short term. Holding Xenon Pharmaceuticals could be a better choice for now!

Xenon Pharmaceuticals has performed better than Editas Medicine in short term. Holding Xenon Pharmaceuticals could be a better choice for now!

Celldex Therapeutics has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 11.68% more returns!

Atricure Inc has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 21.38% more returns!

Xenon Pharmaceuticals has performed better than Array Biopharma in short term. Holding Xenon Pharmaceuticals could be a better choice for now!

Anika Therapeutics has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Anika Therapeutics, about 29.62% more returns!

Arbutus Biopharma has performed better than Xenon Pharmaceuticals in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 2.93% more returns!

Xenon Pharmaceuticals Technical analysis of indicators

Price action analysis of Xenon Pharmaceuticals (XENE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Xenon Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a SELL signal for Xenon Pharmaceuticals in short term but the sell signal is initial and weak.

Xenon Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up

CCI has generated a buy signal for Xenon Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Xenon Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 64.1 and Xenon Pharmaceuticals XENE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Xenon Pharmaceuticals XENE stock. Volume based technical analysis of Xenon Pharmaceuticals XENE stock is negative.

Xenon Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock XENE Xenon Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And XENE Experts View which covers a lot of information including buying and selling signals

XENE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Xenon Pharmaceuticals or View Candle Stick Charts here

Chart Xenon Pharmaceuticals (XENE)  Technical (Analysis) Reports Xenon Pharmaceuticals [

Videos related to: Xenon Pharmaceuticals (XENE) Technical (Analysis) Reports Xenon Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Xenon Pharmaceuticals (XENE)  Technical (Analysis) Reports Xenon Pharmaceuticals [

 

Back to top